secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0000950170-22-027006
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Terns Pharmaceuticals prices $75M public offering of 10.35M shares at $7.25
---------------------------------------------------------------------------

- Underwritten offering of 10,350,000 shares at $7.25 per share; gross proceeds ~$75M.
- Underwriters' option for 1,552,500 additional shares exercised in full; net proceeds ~$80.8M.
- Proceeds to advance TERN-501, TERN-701, and TERN-601 clinical programs and for working capital.
- Lead book-runners: Jefferies and Cowen; co-managers: UBS, Mizuho, JMP Securities.
- Offering priced Dec 20, 2022; closed Dec 23, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017022027006/0000950170-22-027006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017022027006/tern-20221220.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-027006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer